broggini massimo
机构: Istituto Mario Negri
每年引用次数
引用次数
引用: 12,180
H-指数: 63
I10-指数 : 195
出版物: 401
Monoclonal gammopathy of uncertain significance in rheumatic disease
Chelazzi G , Cavallo A , Cappelli A , Crespi E
Recenti progressi in medicina 81 ( 5) 306
5
1990
Differential distribution of antitumor agents in primary and secondary tumors.
Broggini M , Garattini S , Colombo T , Donelli Mg
Cancer treatment reports 61 ( 7) 1319 -1324
37
1977
Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.
Morasca L , Broggini M , Sessa C , Mangioni C
Cancer treatment reports 64 845 -854
27
1980
Effects of DNA damaging agents on gene expression in two human cancer cell lines.
Broggini M , D'Incalci M , Vikhanskaya F
Cellular and Molecular Biology 39 ( 8) 855 -862
7
1993
Biodegradable microcarriers as cell delivery vehicle for in vivo transplantation and magnetic resonance monitoring.
Broggini M , Bonizzi L , Moretti M , Galliera E
Journal of Biological Regulators and Homeostatic Agents 25
5
2011
Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
Broggini M , D'Incalci M , Colombo T , Rossi C
Cancer treatment reports 66 ( 1) 127 -133
5
1982
Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits.
Broggini M , Donelli Mg , Sommacampagna B , Paolini A
Cancer treatment reports 70 ( 6) 697 -702
6
1986
Hepatobiliary metabolism and urinary excretion of 4-demethoxydaunorubicin as compared to daunorubicin in rats.
Catapano Cv , Broggini M , Bartosek I , Guaitani A
Anticancer Research 8 ( 4) 725 -732
4
1988
Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors.
Broggini M , Colombo T , Donelli Mg , Marmonti L
Cancer treatment reports 68 ( 5) 739 -747
41
1984
Sequence-specific DNA alkylation of novel tallimustine derivatives
Broggini M , Geroni C , D'Incalci M , Marchini S
Anti-cancer Drug Design 13 ( 3) 193 -205
17
1998
Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.
Broggini M , D'Incalci M , Colombo T
Cancer treatment reports 67 ( 6) 555 -559
14
1983
Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
Gescher A , Broggini M , D'Incalci M , Colombo T
Cancer treatment reports 65 669 -672
7
1981
Problems in the design of anticancer agents.
Broggini M , D'Incalci M , Balconi G , Colombo T
Cancer surveys 8 ( 3) 535 -555
1
1989
Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesions.
Avossa M , Broggini M , Consoli G , Cecconami L
Clinical and Experimental Rheumatology 11 ( 3) 289 -294
11
1993
Modulation of transcription factor--DNA interactions by anticancer drugs.
Broggini M , D'Incalci M
Anti-cancer Drug Design 9 ( 4) 373 -387
36
1994
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells
S. J. Lippard , E. Cvitkovic , M. Broggini , I. Bieche
Prof. Lippard via Erja Kajosalo
86
2011
Sequence-specific DNA interactions by novel alkylating anthracycline derivatives
M. Broggini , C. Geroni , M. Ripamonti , M. D'incalci
Anti-cancer Drug Design 10 ( 8) 641 -653
13
1995
Upregulation of RANKL in Bone Metastatic Breast Cancer Cells afterDirect Co-Culture with Osteogenically Differentiated Human MSCs
M. Broggini , M. Moretti , C. Arrigoni , P. De Luca
Termis-eu 2013
2013
Ottimizzazione dell’erlotinib per il trattamento di pazienti con tumore del polmone avanzato non a piccole cellule: uno studio italiano randomizzato
M. Garassino , M. Broggini , G. Farina , I. Floriani
Convegno annuale AIFA
2009
Sviluppo di patient-derivated xenogafts (PDXS) da tumori rari del torace: un nuovo strumento per lo studio della biologia del tumore e della risposta alla terapia
S. Ferrero , P. Mendogni , F. Ricci , R. Affatato
Congresso Nazionale SICT
2018